Tinearity G1 on national TV channel in Portugal

2024-01-25 11:05

The professor of otology, Leonel Luís, who conducted a pilot study with Tinerity G1 in Portugal has been interviewed in a national TV channel in Portugal. Professor Luís emphasizes that especially normal-hearing people with tinnitus can benefit greatly from Tinearity G1. He also showed the Tinearity G1 during the interview.

70 percent of the patients in the pilot study experienced an improvement in their tinnitus after one month of using Tinearity G1, which is a very good result.

You can watch the TV interview here.

Professor Leonel Luís works at the Hospital de Santa Maria in Lisbon. Professor Luís believes, as was evident in the interview, that the results from the pilot study are very good.

For more information, please contact

Fredrik Westman, CEO
+46 738 - 145 215
fredrik.westman@duearity.com 
www.duearity.com

About Duearity AB (publ)

Duearity is a medtech company that develops and produces solutions aiming to relieve tinnitus symptoms and make everyday life easier for those who suffer from tinnitus. The company will offer the products Tinearity and Tinearity-AI.

Tinearity G1 is CE marked, has 510(k) clearance and is sold in the EU and in the US.

Tinearity transmits white noise using non-invasive Bone Conduction Technology to the inner ear in order to relieve symptoms. Tinearity AI will use artificial intelligence to help people anticipate the symptoms and relieve their discomfort.

The company is listed on Nasdaq First North. The company's headquarters are located in Malmö, Sweden.
Certified Adviser is Svensk Kapitalmarknadsgranskning AB (SKMG), www.skmg.se.
www.duearity.com.

Attachments

Tinearity G1 on national TV channel in Portugal